medicine-news-1/virginia-mason-signs-with-carefx-to-implement-fusionfx-solution-suite-50380-2/;msg90356

Breaking Biology Technology:Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6 Sirius Genomics Announces Change in Leadership 2 Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2 Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3 Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4

[0] Quest Diagnostics Declares Quarterly Cash Dividend [0] Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain [0] Sirius Genomics Announces Change in Leadership [0] Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea

Breaking Medicine Technology:Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 2 Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 3 Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 4 Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2 Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3 Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4 Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2 Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3 Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4 University of Toronto study shows disparity of effect of climate change on UV radiation 9934 1 University of Toronto study shows disparity of effect of climate change on UV radiation 9934 2 University of Miami receives NIH grant to support novel technology for tissue engineering 9930 1 University of Miami receives NIH grant to support novel technology for tissue engineering 9930 2 Seniors Launch Campaign to Have a Fair Say on Health Care Reform 57210 1 Seniors Launch Campaign to Have a Fair Say on Health Care Reform 57210 2

[0] Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes [0] Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders [0] Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy